8-K 2Q 2017 NASDAQLETTER_MARKET VALUE

Company

Arcadia Biosciences, Inc.

Filed

May 30, 2017

Period of Report

May 25, 2017

Accession Number

0001564590-17-011859

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →